Neoral

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Large-scale clinical trials using C(2) monitoring of cyclosporine (CsA) microemulsion (Neoral) in renal transplant recipients… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Everolimus and cyclosporine (CsA) exhibit synergistic immunosuppressive activity when used in combination. We explored… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Calcineurin inhibitors (CNI) are an important component of most immunosuppressive protocols utilized in renal transplantation… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Our clinical trial was designed to investigate the optimal combination of immunosuppressants for renal transplantation… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Cyclosporine (CsA) dosing is traditionally based on trough blood levels (C0) rather than area under the concentration… (More)
Is this relevant?
1998
1998
BACKGROUND We reported that cyclosporine 2-hr postdose levels (C2) correlate better with the AUC0-4 hr than trough levels (C0) in… (More)
Is this relevant?
1998
1998
BACKGROUND Based on the excellent correlation between cyclosporine A 2-hr postdose blood levels (C2) and the area under the… (More)
Is this relevant?
1998
1998
To assess the safety profile of Neoral dose adjustment using cyclosporine (CsA) trough levels (C0) compared with levels obtained… (More)
Is this relevant?
1998
1998
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The pharmacokinetic dose proportionality and relative bioavailability of cyclosporine from a microemulsion formulation… (More)
Is this relevant?